Ekso Bionics (EKSO) CEO to Depart
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Ekso Bionics Announces Leadership Transition
January 21, 2022 4:01 PM ESTBoard Member Steven Sherman to be Appointed CEO
EVP Scott Davis to be Appointed President and COO
CEO Jack Peurach to Leave the Company Effective January 21, 2022
RICHMOND, Calif., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Peurach, who has served as the Companys Chief Executive Officer since 2018, has informed the Companys Board of Directors (the Board) of his... More
